Hengrui Pharmaceutical's anti-cancer drug oxaliplatin passed FDA certification
-
Last Update: 2014-06-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Oxaliplatin for injection is one of the main products of Hengrui medicine, which is mainly used for the first-line treatment of metastatic colorectal cancer and the adjuvant treatment of stage III colorectal cancer after complete resection of the primary tumor As early as August 23, 2012, the product has passed the certification of the Dutch food and Drug Administration and has been approved for sale in the Netherlands According to the EU drug certificate mutual recognition regulation, oxaliplatin for injection can be marketed in any other country in the EU after being approved
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
